UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015843
Receipt number R000018437
Scientific Title Effects of self-care support system using a tablet computer on adherence to self-monitoring in patients with chronic heart failure: A pilot study
Date of disclosure of the study information 2014/12/05
Last modified on 2025/01/19 12:45:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of self-care support system using a tablet computer on adherence to self-monitoring in patients with chronic heart failure: A pilot study

Acronym

Effects of self-care support system using a tablet computer on adherence to self-monitoring in patients with chronic heart failure: A pilot study

Scientific Title

Effects of self-care support system using a tablet computer on adherence to self-monitoring in patients with chronic heart failure: A pilot study

Scientific Title:Acronym

Effects of self-care support system using a tablet computer on adherence to self-monitoring in patients with chronic heart failure: A pilot study

Region

Japan


Condition

Condition

Chronic heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the study is to investigate the effects of self-care support system using a tablet computer on adherence to self-monitoring in patients with chronic heart failure.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adherence to self-monitoring

Key secondary outcomes

1. Ability of self-care behavior
2. Knowledge about heart failure
3. Self-efficacy
4. Quality of life
5. Physical acitivity
6. Salt intake
7. Unplanned visit or telephone consultation to the hospital regarding heart failure care


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Self-care support using a tablet computer

Interventions/Control_2

Usual care using a diary for patients with chronic heart failure

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with chronic heart failure who have a history of hospital admission due to acute exacerbation of heart failure

Key exclusion criteria

Patients who cannot use a tablet computer due to visual impairment, orthopedic disease, or neuromuscular disease

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Tsutsui

Organization

Hokkaido University

Division name

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine

Zip code

060-8638

Address

Kita-15 Nishi-7, Kita-Ku, Sapporo 060-8638, Japan

TEL

011-706-6973

Email

htsutsui@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Yokota

Organization

Hokkaido University Hospital

Division name

Clinical Research and Medical Innovation Center

Zip code

060-8648

Address

Kita-14 Nishi-5, Kita-Ku, Sapporo 060-8648, Japan

TEL

011-706-6001

Homepage URL


Email

t-yokota@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Hokkaido University Hospital

Address

Kita-14 Nishi-5, Kita-Ku, Sapporo 060-8648, Japan

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院、小樽協会病院、市立札幌病院


Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 05 Day


Related information

URL releasing protocol

https://doi.org/10.1093/ehjdh/ztad032

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.1093/ehjdh/ztad032

Number of participants that the trial has enrolled

24

Results

We enrolled 24 outpatients with chronic heart failure (HF) who had a history of HF hospitalization. During the 2-month study period, the intervention group showed excellent adherence to the self-monitoring of each vital sign. At 2 months, the intervention group's self-care behavior score (evaluated by the European Heart Failure Self-Care Behaviour Scale) was significantly improved compared to the control group.

Results date posted

2023 Year 05 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 05 Month 10 Day

Baseline Characteristics

The median age (interquartile range; IQR) of the total chronic HF cohort was 60 (50-67) years; 18 (75%) of the patients were men, and six (25%) were women. Twenty-five percent of the patients were living alone. Of the total cohort, 58% had daily habits of self-monitoring before being enrolled in the study, including the measurement of blood pressure using a diary; 38% had a tablet PC or a smartphone. Before their enrollment in the study, 46% of the patients had been hospitalized for worsening HF within the prior 3 months.The primary cause of HF was ischemic heart disease (29% of the patients); dilated cardiomyopathy was the primary cause in 21%, and in the remaining 50% of the patients the causes were hypertrophic cardiomyopathy, cardiac sarcoidosis, tachycardia-induced cardiomyopathy, hypertensive heart disease, and valvular heart disease. In addition, most of the patients had a reduced left ventricular ejection fraction (median [IQR]: 32 [24-46] %).

Participant flow

We recruited patients with chronic HF who were followed at the outpatient ward of each participating hospital. Written informed consent was obtained from each patient before his or her participation in the study. After we obtained a participant's written informed consent, participants were randomly assigned in a 1:1 fashion to either the self-care support mobile app intervention group or the control (i.e., usual-care) group. The patients were followed by cardiologists at the outpatient ward of each hospital for 2 months. During the study period, two visits (at 1 month and at 2 months) were the minimum scheduled outpatient visits after the initiation of the study.

Adverse events

There were no adverse events in either of participants during study period.

Outcome measures

The primary compliance outcome measure was adherence to the self-monitoring of four core vital signs (blood pressure, body weight, body temperature, and oxygen saturation) for 2 months. The adherence to self-monitoring was evaluated by the patient's records in the app (intervention group) or in the HF diary (control group). The study's primary efficacy outcome measure was self-care behavior evaluated by the European Heart Failure Self-Care Behaviour Scale at 2 months. Other measures included the HF Knowledge Scale, the General Self-Efficacy Scale, and the SF-8 at 2 months.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 24 Day

Date of IRB

2014 Year 08 Month 30 Day

Anticipated trial start date

2014 Year 12 Month 08 Day

Last follow-up date

2015 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 12 Month 04 Day

Last modified on

2025 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018437